Are There Differences in Hospital Cost Between Patients With Nosocomial Methicillin-ResistantStaphylococcus aureusBloodstream Infection and Those With Methicillin-SusceptibleS. aureusBloodstream Infection?

This publication has 40 references indexed in Scilit:

• Inappropriate therapy for methicillin-resistant Staphylococcus aureus: Resource utilization and cost implications*
  Critical Care Medicine, 2008
• Secular changes in incidence and mortality associated with Staphylococcus aureus bacteraemia in Quebec, Canada, 1991–2005.
  Clinical Microbiology & Infection, 2008
• Morbidity and cost burden of methicillin-resistant Staphylococcus aureus in early onset ventilator-associated pneumonia
  Critical Care, 2006
• Impact of initial antibiotic choice and delayed appropriate treatment on the outcome of Staphylococcus aureus bacteremia
  European Journal of Clinical Microbiology & Infectious Diseases, 2006
• Clinical and economic impact of methicillin resistance in patients with Staphylococcus aureus bacteremia
  Diagnostic Microbiology and Infectious Disease, 2005
• Comparison of Mortality Associated with Methicillin‐Resistant and Methicillin‐SusceptibleStaphylococcus aureusBacteremia: A Meta‐analysis
  Clinical Infectious Diseases, 2003
• The Economic Impact of Methicillin-Resistant Staphylococcus aureus in Canadian Hospitals
  Infection Control & Hospital Epidemiology, 2001
• Applied Logistic Regression
  Technometrics, 1992
• A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation
  Journal of Chronic Diseases, 1987
• The central role of the propensity score in observational studies for causal effects
  Biometrika, 1983